In our analysis, we identified two target gene clusters of biochanin A including inflammatory genes (IL1A, IL2, and IL6R) and cell proliferation genes (CCND1, PPARG, and EGFR) relevant to the treatment of CRC/COVID-19. This evidence concerns the gene IL6R and colorectal carcinoma.